Smart Holdings, Inc. (PINK:SMHS) reached up 62.50% in morning trading to $.0052 with 12M shares traded. Smart Holdings, Inc., through its wholly owned subsidiary, Assurance Group Direct, is in the business of selling automotive extended service plans on a nationwide basis directly to consumers through national television advertising and internet marketing, while continuing to add new product lines in the personal protection categories. Smart Holdings, Inc. (SMHS.PK), dba Assurance Group Direct announced today it is planning on launching a National TV Campaign offering US FDA approved brand name and generic drugs as early as July 25th or August 1st, 2011.
Double Eagle Holdings, Ltd. (OTCQB: DEGH) reached up 33.33% in morning trading to $.44 with 300K shares traded. Double Eagle Holdings is an innovative consumer products holding company and the parent company of Fuse Science, Inc. Based in Aventura, Florida, Fuse Science is the developer of patent-pending conveyance technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals, delivering their benefits faster and more effectively than ever before. Double Eagle Holdings, Ltd. (OTCQB: DEGH) announced today that it has successfully completed its first round of seed funding.
MultiCell Technologies, Inc. (OTCBB:MCET) reached up 41.18% in morning trading to $.012 with 33M shares traded. MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. MultiCell Technologies, Inc. (OTC Bulletin Board:MCET.ob - News) ("MultiCell") today announced that it entered into a sponsored research agreement with University Health Network pursuant to which Anand Ghanekar, M.D., Ph.D., of the University Health Network's Toronto General Hospital, will direct research activities relating to the evaluation of MultiCell's product candidates MCT-465 and MCT-485, in in vitro models for the treatment of primary liver cancer. The mechanism of action of MCT-465 and MCT-485 and their potential selective effect on liver cancer stem cells will also be evaluated.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
